Comparison between IFN induction, induction plus Ribavirin and IFN plus Ribavirin combination therapy in naive patients with chronic hepatitis C related to genotype 1

被引：2
|
作者：
Bellobuono, A [1 ]
Tempini, S [1 ]
Idéo, GM [1 ]
Grimoldi, D [1 ]
Brasca, P [1 ]
Idéo, G [1 ]
机构：
[1] S Giuseppe Hosp, Ctr Liver Dis, Milan, Italy
来源：
JOURNAL OF HEPATOLOGY | 2000年 / 32卷
关键词：
D O I：
10.1016/S0168-8278(00)80755-2
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：110 / 110
页数：1
相关论文
共 50 条
  • [21] Response of TT virus to IFN plus ribavirin treatment in patients with chronic hepatitis C
    JavierMoreno
    RafaelBarcena
    SantosdelCampo
    GloriaMoraleda
    Mluisa Mateos
    World Journal of Gastroenterology, 2004, (01) : 143 - 146
  • [22] Response of TT virus to IFN plus ribavirin treatment in patients with chronic hepatitis C
    Moreno, J
    Moraleda, G
    Barcena, R
    Mateos, M
    del Campo, S
    WORLD JOURNAL OF GASTROENTEROLOGY, 2004, 10 (01) : 143 - 146
  • [23] Daily induction intron-A and combination of intron-A plus ribavirin for treatment of chronic hepatitis C in patients with genotype 1.
    Trinh, HN
    HEPATOLOGY, 2000, 32 (04) : 556A - 556A
  • [24] Effect of 12 month αIFN and Ribavirin combination therapy in chronic hepatitis C unresponsive to αIFN
    Bellobuono, A
    Tempini, S
    Grimoldi, D
    Idéo, GM
    Mondazzi, L
    Brasca, P
    Idéo, G
    JOURNAL OF HEPATOLOGY, 2000, 32 : 178 - 178
  • [25] Hematological changes during IFN/ribavirin combination therapy in patients with chronic hepatitis C
    Wichlas, M
    Hofer, H
    Homoncik, M
    Gangl, A
    Ferenci, P
    Peck-Radosavljevic, M
    Kreil, A
    JOURNAL OF HEPATOLOGY, 2002, 36 : 114 - 115
  • [26] Efficacy and tolerability of consensus IFN and ribavirin combination therapy in naive patients affected by chronic hepatitis C with genotype 1 and high viral load.
    Bellobuono, A
    Tempini, S
    Grimoldi, D
    Cattaneo, C
    Bellobuono, A
    Ideo, G
    HEPATOLOGY, 2001, 34 (04) : 337A - 337A
  • [27] Health-related quality of life (HRQOL) with albinterferon alfa-213 plus ribavirin in IFN treatment-naive patients with genotype 1 chronic hepatitis C
    Pianko, S.
    Yoshida, E.
    Zeuzem, S.
    Benhamou, Y.
    Bain, V.
    Pulkstenis, E.
    McHutchison, J. G.
    Subramanian, G. M.
    JOURNAL OF HEPATOLOGY, 2008, 48 : S306 - S307
  • [28] Treatment of chronic hepatitis C in patients who have failed to respond to IFN or IFN and ribavirin combination therapy
    Mazen Alsatie
    Paul Y. Kwo
    Current Hepatitis Reports, 2003, 2 (1) : 32 - 39
  • [29] Combination of interferon induction therapy and ribavirin in chronic hepatitis C
    Ferenci, P
    Brunner, H
    Nachbaur, K
    Datz, C
    Gschwantler, M
    Hofer, H
    Stauber, R
    Hackl, F
    Jessner, W
    Rosenbeiger, M
    Munda-Steindl, P
    Hegenbarth, K
    Gangl, A
    Vogel, W
    HEPATOLOGY, 2001, 34 (05) : 1006 - 1011
  • [30] Emotional distress during IFN plus Ribavirin combination therapy of hepatitis C: A prospective study.
    Fontana, RJ
    Schwartz, SM
    Lok, AS
    Trask, PC
    GASTROENTEROLOGY, 2000, 118 (04) : A1439 - A1439
12345